XML 46 R51.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsidiary Guarantors - Condensed Consolidating Statement of Cash Flows (Details) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 28, 2013
Sep. 29, 2012
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities $ (14,409) $ (14,104)
Investing Activities    
Capital expenditures (8,899) (3,720)
Supply center acquisition (348) 0
Proceeds from sale of assets 49 88
Net cash used in investing activities (9,198) (3,632)
Financing Activities    
Borrowings under ABL facilities 123,944 147,574
Payments under ABL facilities (200,944) (131,353)
Intercompany transactions 0 0
Equity contribution from parent 742 80
Issuance of senior notes 106,000 0
Financing costs (5,445) (225)
Net cash provided by (used in) financing activities 24,297 16,076
Effect of exchange rate changes on cash and cash equivalents (80) (55)
Net increase (decrease) in cash and cash equivalents 610 (1,715)
Cash and cash equivalents at beginning of period 9,594 11,374
Cash and cash equivalents at end of period 10,204 9,659
Company
   
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities (16,872) (22,131)
Investing Activities    
Capital expenditures (8,496) (2,956)
Supply center acquisition (348)  
Proceeds from sale of assets 49 87
Net cash used in investing activities (8,795) (2,869)
Financing Activities    
Borrowings under ABL facilities 79,891 74,218
Payments under ABL facilities (148,391) (74,619)
Intercompany transactions (5,381) 26,410
Equity contribution from parent 742 80
Issuance of senior notes 106,000  
Financing costs (5,030) (209)
Net cash provided by (used in) financing activities 27,831 25,880
Effect of exchange rate changes on cash and cash equivalents 0 0
Net increase (decrease) in cash and cash equivalents 2,164 880
Cash and cash equivalents at beginning of period 7,320 7,855
Cash and cash equivalents at end of period 9,484 8,735
Co-Issuer
   
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities 0 0
Investing Activities    
Capital expenditures 0 0
Supply center acquisition 0  
Proceeds from sale of assets 0 0
Net cash used in investing activities 0 0
Financing Activities    
Borrowings under ABL facilities 0 0
Payments under ABL facilities 0 0
Intercompany transactions 0 0
Equity contribution from parent 0 0
Issuance of senior notes 0  
Financing costs 0 0
Net cash provided by (used in) financing activities 0 0
Effect of exchange rate changes on cash and cash equivalents 0 0
Net increase (decrease) in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period 0 0
Subsidiary Guarantors
   
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities (3,234) 7,028
Investing Activities    
Capital expenditures (10) (67)
Supply center acquisition 0  
Proceeds from sale of assets 0 1
Net cash used in investing activities (10) (66)
Financing Activities    
Borrowings under ABL facilities 0 0
Payments under ABL facilities 0 0
Intercompany transactions 3,244 (6,962)
Equity contribution from parent 0 0
Issuance of senior notes 0  
Financing costs 0 0
Net cash provided by (used in) financing activities 3,244 (6,962)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net increase (decrease) in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period 0 0
Non-Guarantor Subsidiaries
   
Condensed Financial Statements, Captions [Line Items]    
Net cash (used in) provided by operating activities 5,697 999
Investing Activities    
Capital expenditures (393) (697)
Supply center acquisition 0  
Proceeds from sale of assets 0 0
Net cash used in investing activities (393) (697)
Financing Activities    
Borrowings under ABL facilities 44,053 73,356
Payments under ABL facilities (52,553) (56,734)
Intercompany transactions 2,137 (19,448)
Equity contribution from parent 0 0
Issuance of senior notes 0  
Financing costs (415) (16)
Net cash provided by (used in) financing activities (6,778) (2,842)
Effect of exchange rate changes on cash and cash equivalents (80) (55)
Net increase (decrease) in cash and cash equivalents (1,554) (2,595)
Cash and cash equivalents at beginning of period 2,274 3,519
Cash and cash equivalents at end of period $ 720 $ 924